Terms: = Lung cancer AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463 AND Treatment
11 results:
1. Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma.
Ge X; Xu H; Weng S; Zhang Y; Liu L; Wang L; Xing Z; Ba Y; Liu S; Li L; Wang Y; Han X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8951-8968. PubMed ID: 37160628
[TBL] [Abstract] [Full Text] [Related]
2. [Target therapies in translocated ALK lung cancer: treatment management in oncology center of Lazio.].
Ricciardi S; Cecere F; D'Andrea MR; D'Argento E; Gelibter JA; Giusti R; Lugini A; Mansueto G; Nelli F; Rossi L; Russano M; Migliorino MR
Recenti Prog Med; 2020 Dec; 111(12):63e-69e. PubMed ID: 33362185
[TBL] [Abstract] [Full Text] [Related]
3. lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study.
Zhang C; Guo X; Xu Y; Han X; Cai J; Wang X; Wang G
Sao Paulo Med J; 2019; 137(5):423-429. PubMed ID: 31939567
[TBL] [Abstract] [Full Text] [Related]
4. Integrated High Throughput Analysis Identifies GSK3 as a Crucial Determinant of p53-Mediated Apoptosis in lung cancer Cells.
Zhang Y; Zhu C; Sun B; Lv J; Liu Z; Liu S; Li H
Cell Physiol Biochem; 2017; 42(3):1177-1191. PubMed ID: 28662516
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacological targeting of p53 through rita is an effective antitumoral strategy for malignant pleural mesothelioma.
Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
[TBL] [Abstract] [Full Text] [Related]
6. Percutaneous radiofrequency ablation for malignant liver tumours in challenging locations.
Kelogrigoris M; Laspas F; Kyrkou K; Stathopoulos K; Georgiadou V; Thanos L
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):48-54. PubMed ID: 22339745
[TBL] [Abstract] [Full Text] [Related]
7. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
Textor S; Fiegler N; Arnold A; Porgador A; Hofmann TG; Cerwenka A
Cancer Res; 2011 Sep; 71(18):5998-6009. PubMed ID: 21764762
[TBL] [Abstract] [Full Text] [Related]
8. Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells.
Chiu HC; Chou DL; Huang CT; Lin WH; Lien TW; Yen KJ; Hsu JT
Biochem Pharmacol; 2011 Jun; 81(11):1263-70. PubMed ID: 21406185
[TBL] [Abstract] [Full Text] [Related]
9. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: rita trial.
Loibl S; Murmann C; Schwedler K; Warm M; Müller L; Heinrich G; Nekljudova V; von Minckwitz G
Cancer Chemother Pharmacol; 2009 Apr; 63(5):953-8. PubMed ID: 18716777
[TBL] [Abstract] [Full Text] [Related]
10. Combination treatment of vertebral metastases using image-guided percutaneous radiofrequency ablation and vertebroplasty: a case report.
Halpin RJ; Bendok BR; Sato KT; Liu JC; Patel JD; Rosen ST
Surg Neurol; 2005 May; 63(5):469-74; discussion 474-5. PubMed ID: 15883077
[TBL] [Abstract] [Full Text] [Related]
11. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer.
King J; Glenn D; Clark W; Zhao J; Steinke K; Clingan P; Morris DL
Br J Surg; 2004 Feb; 91(2):217-23. PubMed ID: 14760671
[TBL] [Abstract] [Full Text] [Related]
